What's new

EMEA-001716-PIP07-22-M01

EMEA-001716-PIP07-22-M01

Jun 16, 2025 - 13:45
 0
EMEA-001716-PIP07-22-M01
EMEA-001716-PIP07-22-M01
Read More

Tags:

Previous Article

Questions and answers about the SEND proof-of-concept for industry: Scope, term...

Next Article

Paris Air Show blockades off Israeli booths, in move Israel calls ‘outrageous an...

Related Posts

Human medicines European public assessment report (EPAR): Beqvez (previously Durveqtix), fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Revision: 3, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0